We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.11%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$95.1B
AUM Growth
+$8.07B
(+9.3%)
Cap. Flow
-$2.38B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
11.63%
Holding
2,696
New
179
Increased
1,230
Reduced
1,050
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$334M |
| 2 |
Knight Transportation
KNX
|
+$197M |
| 3 |
Zebra Technologies
ZBRA
|
+$192M |
| 4 |
US Foods
USFD
|
+$189M |
| 5 |
Axalta
AXTA
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$247M |
| 2 |
Everest Group
EG
|
+$242M |
| 3 |
Live Nation Entertainment
LYV
|
+$209M |
| 4 |
Tapestry
TPR
|
+$198M |
| 5 |
Molina Healthcare
MOH
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.1% |
| 2 | Industrials | 14.14% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Healthcare | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Nuvation Bio
NUVB
$2.32B
| $29.3K | ﹤0.01% |
19,374
+3,494
| +22% | +$4.5K |
|
2452
Kopin
KOPN
$791M
| $29.1K | ﹤0.01% |
14,337
+2,656
| +23% | +$3.79K |
|
2453
Humacyte
HUMA
$194M
| $28.7K | ﹤0.01% |
+10,099
| New | +$25.9K |
|
|
NBIS
2454
Nebius Group N.V.
NBIS
$47.7B
| $28.2K | ﹤0.01% |
149,103
| – | – |
|
2455
Akebia Therapeutics
AKBA
$252M
| $27.9K | ﹤0.01% |
22,519
-732,969
| -97% | -$748K |
|
|
FSP
2456
Franklin Street Properties
FSP
$46.8M
| $27.8K | ﹤0.01% |
+10,871
| New | +$23.4K |
|
2457
Traeger
COOK
$172M
| $27.7K | ﹤0.01% |
+203
| New | +$26.2K |
|
|
LEV
2458
DELISTED
The Lion Electric Company
LEV
| $27.7K | ﹤0.01% |
+15,627
| New | +$27.2K |
|
2459
Taysha Gene Therapies
TSHA
$1.89B
| $27.6K | ﹤0.01% |
+15,600
| New | +$31.1K |
|
2460
Quantum-Si Incorporated
QSI
$177M
| $26.9K | ﹤0.01% |
13,384
+2,544
| +23% | +$3.88K |
|
2461
Erasca
ERAS
$6.39B
| $26.9K | ﹤0.01% |
12,616
+2,491
| +25% | +$5.25K |
|
2462
Angi Inc
ANGI
$196M
| $26.2K | ﹤0.01% |
+1,051
| New | +$21.5K |
|
2463
Solid Power
SLDP
$532M
| $26.1K | ﹤0.01% |
17,978
+4,256
| +31% | +$6.38K |
|
|
ZOM
2464
DELISTED
Zomedica Corp.
ZOM
| $26K | ﹤0.01% |
130,002
+23,386
| +22% | +$4.11K |
|
2465
Lineage Cell Therapeutics
LCTX
$278M
| $25.6K | ﹤0.01% |
23,495
+4,265
| +22% | +$4.67K |
|
2466
SelectQuote
SLQT
$121M
| $24.5K | ﹤0.01% |
17,862
+3,027
| +20% | +$3.95K |
|
2467
Standard BioTools
LAB
$314M
| $24.1K | ﹤0.01% |
+10,927
| New | +$23.3K |
|
|
GRTS
2468
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $24.1K | ﹤0.01% |
+11,826
| New | +$21.6K |
|
2469
Energy Vault
NRGV
$633M
| $23.8K | ﹤0.01% |
+10,220
| New | +$23.6K |
|
|
NVTA
2470
DELISTED
Invitae Corporation
NVTA
| $23.5K | ﹤0.01% |
37,442
+8,687
| +30% | +$5.2K |
|
|
KG
2471
Kestrel Group
KG
$69M
| $23.3K | ﹤0.01% |
+508
| New | +$18.8K |
|
2472
ThredUp
TDUP
$422M
| $22.6K | ﹤0.01% |
+10,043
| New | +$26.1K |
|
2473
Precigen
PGEN
$2.59B
| $22.6K | ﹤0.01% |
16,855
+3,659
| +28% | +$4.3K |
|
|
GOEV
2474
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $22.4K | ﹤0.01% |
190
+70
| +58% | +$9.48K |
|
2475
Eos Energy Enterprises
EOSE
$1.51B
| $22.4K | ﹤0.01% |
20,505
+6,370
| +45% | +$9.29K |
|
Similar funds
VGA
Victory Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Victory Capital Management held 2,696 positions worth $95.1B, up 9.3% from $87B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Victory Capital Management's Q4 2023 filing shows 179 new, 1,230 increased, 1,050 reduced and 159 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,608,317 shares worth $124M. The largest sale was Hewlett Packard, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,608,317 shares worth $124M.
- Victory Capital Management added most to Willis Towers Watson in Q4 2023, an estimated $334M increase.
- Victory Capital Management's biggest Q4 2023 reduction was Hewlett Packard, cutting an estimated $247M.
- Victory Capital Management fully exited iShares Russell 2000 Growth ETF in Q4 2023, selling an estimated $127M.
- Victory Capital Management's ten largest holdings make up 12% of its $95.1B portfolio in Q4 2023.
- Victory Capital Management opened 179 new positions and closed 159 in Q4 2023.
- Victory Capital Management's portfolio value rose 9.3% quarter-over-quarter to $95.1B.
Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.